Similar articles for PMID: 20650522

Year	Number of Results
2000	1
2004	1
2007	2
2008	2
2009	2
2010	8
2011	4
2012	7
2013	10
2014	9
2015	12
2016	7
2017	12
2018	9
2019	7
2020	7
2021	2
2022	1
2023	1
2024	0

1

Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed.

Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Degenhardt L, et al. Lancet. 2010 Jul 24;376(9737):285-301. doi: 10.1016/S0140-6736(10)60742-8. Lancet. 2010. PMID: 20650522

2

The cost-effectiveness of harm reduction.

Wilson DP, Donald B, Shattock AJ, Wilson D, Fraser-Hurt N. Wilson DP, et al. Int J Drug Policy. 2015 Feb;26 Suppl 1:S5-11. doi: 10.1016/j.drugpo.2014.11.007. Epub 2014 Dec 1. Int J Drug Policy. 2015. PMID: 25727260 Free article.

3

Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs.

Reddon H, Marshall BDL, Milloy MJ. Reddon H, et al. Lancet HIV. 2019 Feb;6(2):e128-e136. doi: 10.1016/S2352-3018(18)30292-3. Epub 2018 Dec 14. Lancet HIV. 2019. PMID: 30558843 Free PMC article. Review.

4

Commentary: the value of PrEP for people who inject drugs.

Coleman RL, McLean S. Coleman RL, et al. J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21112. doi: 10.7448/IAS.19.7.21112. eCollection 2016. J Int AIDS Soc. 2016. PMID: 27760686 Free PMC article.

5

Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico.

Cepeda JA, Bórquez A, Magana C, Vo A, Rafful C, Rangel G, Medina-Mora ME, Strathdee S, Martin NK. Cepeda JA, et al. J Int AIDS Soc. 2020 Jun;23 Suppl 1(Suppl 1):e25493. doi: 10.1002/jia2.25493. J Int AIDS Soc. 2020. PMID: 32562375 Free PMC article.

6

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M. Platt L, et al. Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2. Cochrane Database Syst Rev. 2017. PMID: 28922449 Free PMC article. Review.

7

Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.

Dutta A, Wirtz AL, Baral S, Beyrer C, Cleghorn FR. Dutta A, et al. Curr Opin HIV AIDS. 2012 Jul;7(4):362-8. doi: 10.1097/COH.0b013e328354a0b5. Curr Opin HIV AIDS. 2012. PMID: 22647588 Review.

8

Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling.

Vickerman P, Platt L, Jolley E, Rhodes T, Kazatchkine MD, Latypov A. Vickerman P, et al. Int J Drug Policy. 2014 Nov;25(6):1163-73. doi: 10.1016/j.drugpo.2014.09.013. Int J Drug Policy. 2014. PMID: 25449056

9

Effects of combination approach on harm reduction programs: the Taiwan experience.

Lin T, Chen CH, Chou P. Lin T, et al. Harm Reduct J. 2016 Jul 4;13(1):23. doi: 10.1186/s12954-016-0112-3. Harm Reduct J. 2016. PMID: 27377896 Free PMC article.

10

Measures of harm reduction service provision for people who inject drugs.

O'Keefe D, Bluthenthal RN, Kral AH, Aitken CK, McCormack A, Dietze PM. O'Keefe D, et al. Bull World Health Organ. 2019 Sep 1;97(9):605-611. doi: 10.2471/BLT.18.224089. Epub 2019 Jun 20. Bull World Health Organ. 2019. PMID: 31474773 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year